Chemical Component Summary

Name(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
Identifiers(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
FormulaC29 H50 O2
Molecular Weight430.71
TypeNON-POLYMER
Isomeric SMILESCc1c(c2c(c(c1O)C)CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C
InChIInChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1
InChIKeyGVJHHUAWPYXKBD-IEOSBIPESA-N

Chemical Details

Formal Charge0
Atom Count81
Chiral Atom Count3
Bond Count82
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00163 
NameVitamin E
Groups
  • approved
  • nutraceutical
  • vet_approved
DescriptionIn 1922, vitamin E was demonstrated to be an essential nutrient[A32448]. Vitamin E is a term used to describe 8 different fat soluble tocopherols and tocotrienols, alpha-tocopherol being the most biologically active[A176104]. Vitamin E acts as an antioxidant, protecting cell membranes from oxidative damage[A176104]. The antioxidant effects are currently being researched for use in the treatment of diseases causing bone loss, cardiovascular diseases, diabetes mellitus and associated comorbidities, eye diseases, inflammatory diseases (including skin conditions), lipid disorders, neurological diseases, and radiation damage[A176369]. Though this research is so far inconclusive, vitamin E remains a popular supplement and is generally considered safe by the FDA[FDA Label].
Synonyms
  • alpha-tocopherol
  • (R,R,R)-α-tocopherol
  • Vitamin E
  • (2R,4'R,8'R)-α-tocopherol
  • d-α-tocopherol
Brand Names
  • Tma Tab
  • Bear Essentials
  • Black Currant Seed Oil Cap
  • Complete One A Day Tab
  • Ch-P Cap
IndicationVitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet[A176104,L3063].
Categories
  • Antioxidants
  • Basic Ointments and Protectants
  • Benzopyrans
  • Compounds used in a research, industrial, or household setting
  • Cytochrome P-450 CYP3A Inducers
CAS number59-02-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Nuclear receptor subfamily 1 group I member 2MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...unknown
Protein kinase C beta typeMADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFC...unknown
Arachidonate 5-lipoxygenaseMPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGA...unknown
Protein kinase C alpha typeMADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFC...unknown
Diacylglycerol kinase alphaMAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGY...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem14985
ChEBICHEBI:18145
ChEMBLCHEMBL47